WBR0278: Difference between revisions

Jump to navigation Jump to search
No edit summary
m (refreshing WBR questions)
 
(5 intermediate revisions by 2 users not shown)
Line 1: Line 1:
{{WBRQuestion
{{WBRQuestion
|QuestionAuthor={{Ochuko}} {{Alison}}
|QuestionAuthor= {{Ochuko}} (Reviewed by Will Gibson,  {{YD}},  {{AJL}})
|ExamType=USMLE Step 1
|ExamType=USMLE Step 1
|MainCategory=Genetics, Pathology
|MainCategory=Genetics
|SubCategory=Oncology, Renal
|SubCategory=Oncology, Renal
|MainCategory=Genetics, Pathology
|MainCategory=Genetics
|SubCategory=Oncology, Renal
|SubCategory=Oncology, Renal
|MainCategory=Genetics, Pathology
|MainCategory=Genetics
|SubCategory=Oncology, Renal
|SubCategory=Oncology, Renal
|MainCategory=Genetics, Pathology
|MainCategory=Genetics
|MainCategory=Genetics, Pathology
|MainCategory=Genetics
|MainCategory=Genetics, Pathology
|MainCategory=Genetics
|SubCategory=Oncology, Renal
|SubCategory=Oncology, Renal
|MainCategory=Genetics, Pathology
|MainCategory=Genetics
|SubCategory=Oncology, Renal
|SubCategory=Oncology, Renal
|MainCategory=Genetics, Pathology
|MainCategory=Genetics
|SubCategory=Oncology, Renal
|SubCategory=Oncology, Renal
|MainCategory=Genetics, Pathology
|MainCategory=Genetics
|SubCategory=Oncology, Renal
|SubCategory=Oncology, Renal
|MainCategory=Genetics, Pathology
|MainCategory=Genetics
|MainCategory=Genetics, Pathology
|MainCategory=Genetics
|SubCategory=Oncology, Renal
|SubCategory=Oncology, Renal
|Prompt=A 2-year-old boy is brought to the ER by his mother for bloody urine and abdominal pain. Upon physical examination, the physician palpates a large abdominal mass on the right flank. An abdominal X-ray reveals a large soft tissue opacity displacing the bowel. CT scan displays heterogeneous soft tissue masses with frequent areas of calcifications and fatty regions. On MRI, the tumor appears heterogeneous on all sequences.  Which one of the following genetic alterations is most likely responsible for this patient's presentation?
|Prompt=A 3-year-old boy is brought to the pediatrician's office by his mother for bloody urine and abdominal pain. His temperature is 37.2 °C (98.96 °F), blood pressure is 144/90 mmHg, and heart rate is 70/min. Physical examination is remarkable for a large abdominal mass. Abdominal ultrasonography confirms the presence of a renal mass. CT scan demonstrates a solid renal mass with normal renal parenchyma towards its rim (claw sign). Which one of the following genetic alterations is responsible for this patient's condition?
|Explanation=The patient in this scenario has [[nephroblastoma]] ([[Wilms tumor]]), a pediatric kidney cancer that arises from pluripotent embryonic renal progenitor cells. [[Nephroblastoma]] often manifests as a huge palpable flank mass and/or hematuria. [[Nephroblastoma]] is the most common renal malignancy that occurs in early childhood (ages 2-4 years). Both germline and somatic cases of nephroblastoma are associated with inactivation mutations or deletions of the WT1 gene on chromosome 11p. This gene encodes a transcription factor that normally functions in the differentiation of renal and genitourinary tissue. [[Nephroblastoma]] may be part of Denys-Drash syndrome or the WAGR complex: Wilms’ tumor, Aniridia, Genitourinary malformation, and mental-motor Retardation. Wilm's tumor is highly responsive to treatment with surgery, radiation and chemotherapy (protocol DD-4A).
|Explanation=[[Nephroblastoma]] ([[Wilms tumor]]) is the most common pediatric [[kidney cancer]]. It arises from the pluripotent embryonic [[renal progenitor cell]]s. [[Nephroblastoma]] usually manifests as a palpable [[abdominal mass]] that does not cross the midline. In addition, [[hematuria]] and [[high blood pressure]] may be present in 25% of the cases and suggest invasion of the [[renal pelvis]] and compression of the [[renal arteries]], respectively. In advanced cases, [[metastasis]] may be present in the [[abdominal lymph nodes]] and the [[lung]]s. Unlike [[neuroblastoma]], nephroblastoma rarely metastasizes to the bone, and patients rarely have symptoms of bone invasion ([[bone pain]], [[fracture]]s, or [[cytopenia]]s).  
|AnswerA=Mutation of WT1 gene on chromosome 11p11
 
|AnswerAExp=Nephroblastoma (Wilm's tumor) is often caused by mutation or deletion of WT1, the eponymously named Wilm's Tumor 1 gene.
Nephroblastoma may be present in isolation or may be caused by genetic deletions that involve the ''[[WT1]]'' [[tumor suppressor gene]] in [[chromosome]] 11 that result in [[WAGR syndrome]] (Wilms tumor, [[aniridia]], [[genitourinary abnormalities]], and [[retardation]]). ''WT1'' gene encodes a transcription factor that normally functions in the differentiation of renal and genitourinary tissue. Nephroblastoma has also been associated with [[Beckwith-Weidemann syndrome]] (characterized by [[hemihypertrophy]] of organs).
|AnswerB=Mutation of TSC2
 
|AnswerBExp=TSC2 is a tumor suppressor in the MTOR pathway. Mutations in TSC2 cause [[tuberous sclerosis]], which is characterized by the growth of benign tumors in the brain, skin, kidneys and other organs.
Generally, children with a palpable abdominal mass should first undergo an [[abdominal ultrasound]]; suspicious findings warrant an [[abdominal CT scan]]. The classical finding of nephroblastoma on abdominal CT scan include a solid renal mass with normal renal parenchyma towards its rim ([[claw sign]]), as observed in this patient. In contrast to neuroblastoma, calcifications are rare in nephroblastoma. Nephroblastoma is generally managed surgically followed by [[chemotherapy]]. [[Radiotherapy]] is reserved for advanced cases with metastasis. Upon resection, microscopic analysis of the tumor typically reveals immature blasts with primitive glomeruli, fibrous cells, and tubules.
|AnswerC=Mutation of VHL
|AnswerA=Deletion on chromosome 11
|AnswerCExp=The VHL gene encodes a ubiquitin-ligase responsible for increasing the degradation of Hypoxia-Inducible Factor (HIF), a transcription factor that increases the transcription of a variety of gene products including Vascular Endothelial Growth Factor. When the VHL gene is inactivated, HIF activity increases uncontrolled and initiates tumor formation in kidney cells. Germline mutations in the Von-Hippau-Lindau (VHL) tumor suppressor gene cause the Von-Hippau-Lindau cancer predisposition syndrome.
|AnswerAExp=[[Nephroblastoma]] (Wilms or [[Wilms' tumor]]) is often caused by ''WT1'' tumor suppressor gene deletion on chromosome 11. ''WT1'' is eponymously named Wilms Tumor 1 gene.
|AnswerD=Deletion of chromosome 11p15.5
|AnswerB=Mutation of ''TSC2''
|AnswerDExp=Deletion of chromosome 11p15.5 is associated with [[Beckwith-Wiedemann syndrome]].  The causal gene in the regions is unknown but may include CDKN1C, H19 or IGF-2.
|AnswerBExp=''[[TSC2]]'' is a tumor suppressor gene in the [[MTOR]] pathway. Mutations in ''TSC2'' cause [[tuberous sclerosis]], which is characterized by the growth of benign tumors in the brain, skin, kidneys, and other organs.
|AnswerE=t(2;13) translocation
|AnswerC=Mutation of ''VHL''
|AnswerEExp=A t(2;13) translocation is associated with [[rhabdomyosarcoma]].  This translocation fuses he FOXO1 gene from chromosome 13 and the PAX3 gene from chromosome 2 (not high-yield for the USMLE).
|AnswerCExp=The [[Von-Hippau-Lindau]] (''[[VHL]]'') gene encodes a ubiquitin-ligase responsible for increasing the degradation of Hypoxia-Inducible Factor (HIF), a transcription factor involved in a variety of gene products, such as Vascular Endothelial Growth Factor ([[VEGF]]). When the ''VHL'' gene is inactivated, HIF activity increases uncontrollably and initiates tumor formation in kidney cells. Germline mutations in the ''VHL'' tumor suppressor gene are associated with Von-Hippau-Lindau, a cancer-predisposing syndrome.
|EducationalObjectives=[[Nephroblastoma]] ([[Wilms tumor]]) is associated with the deletion of WT1 genes on chromosome 11p11.
|AnswerD=Trinucleotide repeats
|AnswerDExp=Trinucleotide repeats is not associated with nephroblastoma. Huntington's disease (CAG repeats), myotonic dystrophy (CTG repeats), Fragile X syndrome (GAA repeats), and Friedreich ataxia (GAA repeats) are caused by trinucleotide repeats.
|AnswerE=Translocation t(2;13)
|AnswerEExp=Translocation t(2;13) is associated with [[rhabdomyosarcoma]].  This translocation fuses the ''FOXO1'' gene from chromosome 13 and the ''PAX3'' gene from chromosome 2.
|EducationalObjectives=[[Nephroblastoma]] ([[Wilms tumor]]) is associated with ''WT1'' gene deletion on chromosome 11.
|References=Lee SB, Haber DA. Wilms tumor and the WT1 gene. Exp Cell Res. 2001;264(1):74-99.<br>
|References=Lee SB, Haber DA. Wilms tumor and the WT1 gene. Exp Cell Res. 2001;264(1):74-99.<br>
Nakamura L, Ritchey M. Current management of wilms' tumor. Curr Urol Rep. 2010;11(1):58-65.<br>
Nakamura L, Ritchey M. Current management of wilms' tumor. Curr Urol Rep. 2010;11(1):58-65.<br>
Friedman AD. Wilms tumor. Pediatr Rev. 2013;34(7):328-30; discussion 330.<br>
First Aid 2014 page 541
First Aid 2014 page 541
|RightAnswer=A
|RightAnswer=A
|WBRKeyword=Cancer, Tumor, Wilm's tumor, Childhood cancer, Pediatric cancer, Nephroblastoma, Genetics, Cancer genetics
|WBRKeyword=Cancer, Tumor, Wilm's tumor, Wilms tumor, Kidney cancer, Beckwith-Weidemann syndrome, Childhood cancer, Pediatric cancer, Nephroblastoma, WT1, Tumor suppressor gene, WAGR syndrome, WAGR complex,
|Approved=Yes
|Approved=Yes
}}
}}

Latest revision as of 00:02, 28 October 2020

 
Author [[PageAuthor::Ogheneochuko Ajari, MB.BS, MS [1] (Reviewed by Will Gibson, Yazan Daaboul, M.D., Alison Leibowitz [2])]]
Exam Type ExamType::USMLE Step 1
Main Category MainCategory::Genetics
Sub Category SubCategory::Oncology, SubCategory::Renal
Prompt [[Prompt::A 3-year-old boy is brought to the pediatrician's office by his mother for bloody urine and abdominal pain. His temperature is 37.2 °C (98.96 °F), blood pressure is 144/90 mmHg, and heart rate is 70/min. Physical examination is remarkable for a large abdominal mass. Abdominal ultrasonography confirms the presence of a renal mass. CT scan demonstrates a solid renal mass with normal renal parenchyma towards its rim (claw sign). Which one of the following genetic alterations is responsible for this patient's condition?]]
Answer A AnswerA::Deletion on chromosome 11
Answer A Explanation [[AnswerAExp::Nephroblastoma (Wilms or Wilms' tumor) is often caused by WT1 tumor suppressor gene deletion on chromosome 11. WT1 is eponymously named Wilms Tumor 1 gene.]]
Answer B AnswerB::Mutation of ''TSC2''
Answer B Explanation [[AnswerBExp::TSC2 is a tumor suppressor gene in the MTOR pathway. Mutations in TSC2 cause tuberous sclerosis, which is characterized by the growth of benign tumors in the brain, skin, kidneys, and other organs.]]
Answer C AnswerC::Mutation of ''VHL''
Answer C Explanation [[AnswerCExp::The Von-Hippau-Lindau (VHL) gene encodes a ubiquitin-ligase responsible for increasing the degradation of Hypoxia-Inducible Factor (HIF), a transcription factor involved in a variety of gene products, such as Vascular Endothelial Growth Factor (VEGF). When the VHL gene is inactivated, HIF activity increases uncontrollably and initiates tumor formation in kidney cells. Germline mutations in the VHL tumor suppressor gene are associated with Von-Hippau-Lindau, a cancer-predisposing syndrome.]]
Answer D AnswerD::Trinucleotide repeats
Answer D Explanation AnswerDExp::Trinucleotide repeats is not associated with nephroblastoma. Huntington's disease (CAG repeats), myotonic dystrophy (CTG repeats), Fragile X syndrome (GAA repeats), and Friedreich ataxia (GAA repeats) are caused by trinucleotide repeats.
Answer E AnswerE::Translocation t(2;13)
Answer E Explanation [[AnswerEExp::Translocation t(2;13) is associated with rhabdomyosarcoma. This translocation fuses the FOXO1 gene from chromosome 13 and the PAX3 gene from chromosome 2.]]
Right Answer RightAnswer::A
Explanation [[Explanation::Nephroblastoma (Wilms tumor) is the most common pediatric kidney cancer. It arises from the pluripotent embryonic renal progenitor cells. Nephroblastoma usually manifests as a palpable abdominal mass that does not cross the midline. In addition, hematuria and high blood pressure may be present in 25% of the cases and suggest invasion of the renal pelvis and compression of the renal arteries, respectively. In advanced cases, metastasis may be present in the abdominal lymph nodes and the lungs. Unlike neuroblastoma, nephroblastoma rarely metastasizes to the bone, and patients rarely have symptoms of bone invasion (bone pain, fractures, or cytopenias).

Nephroblastoma may be present in isolation or may be caused by genetic deletions that involve the WT1 tumor suppressor gene in chromosome 11 that result in WAGR syndrome (Wilms tumor, aniridia, genitourinary abnormalities, and retardation). WT1 gene encodes a transcription factor that normally functions in the differentiation of renal and genitourinary tissue. Nephroblastoma has also been associated with Beckwith-Weidemann syndrome (characterized by hemihypertrophy of organs).

Generally, children with a palpable abdominal mass should first undergo an abdominal ultrasound; suspicious findings warrant an abdominal CT scan. The classical finding of nephroblastoma on abdominal CT scan include a solid renal mass with normal renal parenchyma towards its rim (claw sign), as observed in this patient. In contrast to neuroblastoma, calcifications are rare in nephroblastoma. Nephroblastoma is generally managed surgically followed by chemotherapy. Radiotherapy is reserved for advanced cases with metastasis. Upon resection, microscopic analysis of the tumor typically reveals immature blasts with primitive glomeruli, fibrous cells, and tubules.
Educational Objective: Nephroblastoma (Wilms tumor) is associated with WT1 gene deletion on chromosome 11.
References: Lee SB, Haber DA. Wilms tumor and the WT1 gene. Exp Cell Res. 2001;264(1):74-99.
Nakamura L, Ritchey M. Current management of wilms' tumor. Curr Urol Rep. 2010;11(1):58-65.
Friedman AD. Wilms tumor. Pediatr Rev. 2013;34(7):328-30; discussion 330.
First Aid 2014 page 541]]

Approved Approved::Yes
Keyword WBRKeyword::Cancer, WBRKeyword::Tumor, WBRKeyword::Wilm's tumor, WBRKeyword::Wilms tumor, WBRKeyword::Kidney cancer, WBRKeyword::Beckwith-Weidemann syndrome, WBRKeyword::Childhood cancer, WBRKeyword::Pediatric cancer, WBRKeyword::Nephroblastoma, WBRKeyword::WT1, WBRKeyword::Tumor suppressor gene, WBRKeyword::WAGR syndrome, WBRKeyword::WAGR complex
Linked Question Linked::
Order in Linked Questions LinkedOrder::